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Dissection of Signaling Cascades through gp130
In Vivo: Reciprocal Roles for STAT3-
and SHP2-Mediated Signals in Immune Responses
Stahl et al., 1994), leading to the recruitment of signal
transducing molecules such as SHP2 (protein tyrosine
phosphatase 2) and STAT3. gp130 contains six tyrosines
in its cytoplasmic region (Hibi et al., 1990). Tyr-759 (of
human gp130) and any one of four tyrosines in the car-
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and Toshio Hirano*§ boxyl terminus (Tyr-767, -814, -905, and -915), which
have a glutamine at position 13 of tyrosine (YXXQ motif),*Division of Molecular Oncology (C7)
²Division of Neuroanatomy (D12) are required for the tyrosine phosphorylation of SHP2
and STAT3, respectively (Stahl et al., 1995; YamanakaBiomedical Research Center
Osaka University Graduate School of Medicine et al., 1996). Tyr-759 is required for the tyrosine phos-
phorylation of SHP-2 and the activation of ERK MAP³Core Research for Evolutional Science and Technology
(CREST) kinase (Stahl et al., 1995; Fukada et al., 1996), although
its negative role is also suggested in STAT3-mediatedJapan Science and Technology Corporation (JST)
2±2 Yamada-oka, Suita biological actions (Symes et al., 1997; Kim et al., 1998).
The SHP2- and STAT3-mediated signals through gp130Osaka 565±0871
Japan are implicated to be involved in growth, differentiation,
and gene expression in certain cells and cell lines (Fu-
kada et al., 1996, 1998; Nakajima et al., 1996; Yamanaka
et al., 1996; Bonni et al., 1997; Kim et al., 1998; NiwaSummary
et al., 1998)(also see a review by Hirano et al., 1997).
However, when and where the SHP2- and STAT3-medi-We generated a series of knockin mouse lines, in
ated signals play critical roles in vivo remains to bewhich the cytokine receptor gp130-dependent STAT3
elucidated.and/or SHP2 signals were disrupted, by replacing the
Targeted disruption in mice of the genes encoding IL-6mouse gp130 gene with human gp130 mutant cDNAs.
family cytokines and gp130 has revealed the rolesThe SHP2 signal±deficient mice (gp130F759/F759) were
played by gp130-mediated signals in vivo. IL-6-deficientborn normal but displayed splenomegaly and lymph-
mice display dysfunction in hematopoiesis (Kopf et al.,adenopathy and an enhanced acute phase reaction. In
1995), the acute phase reaction (Kopf et al., 1995), Th1contrast, the STAT3 signal±deficient mice (gp130FXXQ/FXXQ)
development (Romani et al., 1996; Ladel et al., 1997;died perinatally, like the gp130-deficient mice (gp130D/D).
Suzuki et al., 1997), and antigen-specific antibody pro-The gp130F759/F759 mice showed prolonged gp130-
duction (Kopf et al., 1995; 1998). LIF-deficient mice dis-induced STAT3 activation, indicating a negative regu-
play defects in hematopoiesis and thymocyte prolifera-latory role for SHP2. Th1-type cytokine production and
tion (Escary et al., 1993). CNTF-deficient mice haveIgG2a and IgG2b production were increased in the
slightly fewer motor neurons (Masu et al., 1993). gp130-gp130F759/F759 mice, while they were decreased in the
deficient mice have severe defects in hematopoiesis andgp130FXXQ/FXXQ immune system. These results indicate
thymocyte development and a hypoblastic ventricularthat the balance of positive and negative signals gen-
myocardium, resulting in embryonic lethality (Yoshida eterated through gp130 regulates the immune responses.
al., 1996). Postnatally induced inactivation of the gp130
gene led to the identification of roles for gp130 in
Introduction Schwann cell development, antigen-specific antibody
production, and protection from viral and bacterial infec-
Interleukin-6 (IL-6) is a cytokine that affects a variety of tions (Betz et al., 1998). Transgenic mice expressing a
biological functions, including immunoglobulin produc- dominant-negative gp130 have impaired antigen-spe-
tion, acute-phase reaction, and inflammation (Sehgal et cific antibody production (Kumanogoh et al., 1997). It is
al., 1989; Van Snick, 1990; Hirano, 1998). The IL-6 recep- not yet known, however, how the signal(s) mediated by
tor consists of a chain and gp130, which is shared gp130 lead to the different phenotypes observed in
among the receptors for the other IL-6 family cytokines, these mice, or precisely which pathway(s) is affected in
leukemia inhibitory factor (LIF), ciliary neurotrophic fac- each case.
tor (CNTF), oncostatin M (OSM), IL-11, and cardio- To address these questions and reveal novel roles for
trophin-1 (CT-1) (Hirano et al., 1997). Binding of the IL-6 the SHP2- and STAT3-mediated signals generated from
family cytokines to their receptors activates Janus ki- gp130 in vivo, we generated a series of knockin mouse
nases (JAK1, JAK2, and TYK2) (Lutticken et al., 1994; lines, in which the SHP2- and/or STAT3-mediated sig-
nals are specifically disrupted.
§ To whom correspondence should be addressed (e-mail: hirano@
molonc.med.osaka-u.ac.jp). Results‖ Present address: Cold Spring Harbor Laboratory, Cold Spring Har-
bor, New York 11724.
Generation of Knockin Mice#Present address: Unit on Vertebrate Neural Development, Lab of
We constructed four knockin vectors to generate miceMolecular Genetics, NICHD/NIH, Building 6B, Room 3B-315, 9000
Rockville Pike, Bethesda, Maryland 20892. deficient in the individual signals that are relayed
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Figure 1. Generation of Knockin Mice
(A) Schematic diagram of the mouse endogenous locus for gp130, knockin vectors, and the resulting gp130 proteins after homologous
recombination. The EcoRI site at the 59 side of the exon containing the transmembrane region was used to replace the transmembrane and
cytoplasmic regions with human gp130 cDNA. To make the gp130D/D mutant, a stop codon (asterisk) was introduced at the 39 side of the EcoRI
site. Hatched boxes at the top correspond to exons. Knockin vectors contained wild-type (gp130H/H), mutant (gp130F759/F759 and gp130FXXQ/FXXQ),
or truncated (gp130D/D) human gp130 cDNAs. A, ApaI; B, BamHI; BII, BglII; E, EcoRI; EII, BstEII; H, HindIII; K, KpnI; X, XbaI; Xh, XhoI.
(B) Expression of gp130 on splenic T cells and B cells. Spleen cells from a gp130F759/F759 knockin mouse (lower panels) and a control gp130WT/F759
mouse (upper panels) at 11 weeks of age were used. Straight and broken lines indicate the histograms of gp130 antibody and control IgG2a
stainings, respectively.
(C) Tyrosine phosphorylation of STAT3 and SHP2 in EFs from knockin mice. Cells were stimulated for 15 min with 100 ng/ml IL-6 and sIL-6R.
Cells were lysed and immunoprecipitated with anti-STAT3 or anti-SHP2 antibodies. Tyrosine phosphorylation and the amount of SHP2 and
STAT3 were examined by immunoblotting with antibodies to anti-phosphotyrosine and to each molecule.
(D) Uncoupling of SHP2 resulted in the loss of ERK MAP kinase activation. EFs were stimulated with IL-6 and sIL-6R or 10 ng/ml TPA for 15
min. Cells were lysed and immunoblotted with anti-active MAP kinase antibody (upper panels). The cell lysate was immunoprecipitated with
anti-STAT3 antibody and immunoblotted with anti-phosphotyrosine antibody (lower panel).
(E) Prolonged phosphorylation of signaling molecules in gp130F759/F759 EF. gp130H/H and gp130F759/F759 EFs were stimulated with IL-6 and sIL-6R
for the indicated periods. Cells were lysed and immunoprecipitated with anti-gp130, anti-Jak1, or anti-STAT3 antibodies and immunoblotted
with anti-phosphotyrosine antibody.
through gp130 (Figure 1A). A cDNA fragment, including cDNAs were introduced into the mouse gp130 gene in
a similar manner. These mutants were gp130F759, in whichpart of the extracellular domain and the transmembrane
and cytoplasmic domains of human gp130, was used Tyr-759 was replaced by a phenylalanine, and gp130FXXQ,
in which Tyr-767, -814, -905, and -915 (correspondingto replace the corresponding sequences of the mouse
gp130 gene, yielding a mouse-human chimeric gp130 to YXXQ motifs) were replaced by phenylalanines (Fig-
ure 1A). To disrupt all the gp130-mediated signals, a stop(gp130H) (Figure 1A). The other human gp130 mutant
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codon was introduced at the position amino-terminal to presence of IL-6 family cytokines, approximately 15%
of the cells became GFAP (glial fibrillary acidic protein)-the transmembrane domain (gp130D), which generated
positive astrocytes within 7 days (Figure 2B). Explantsa truncated and soluble form of mouse gp130 (Fig-
from the gp130D/D mice did not respond to IL-6, CNTF,ure 1A). The expression levels of the chimeric gp130
or OSM to generate GFAP1 cells (Figure 2B, right panel).proteins in CD41 and CD81 T cells, B2201 B cells,
When explants from the gp130FXXQ/FXXQ mice were cul-and embryonic fibroblasts (EFs) of the gp130H/H and
tured with IL-6 and sIL-6R, GFAP1 astrocytes were notgp130F759/F759 mice were comparable to those of wild-
induced (Figure 2B, middle panel). However, when theytype gp130 (Figures 1B and 1E), suggesting that the
were cultured with CNTF or OSM, the generation ofmutations in gp130 did not affect its surface expression.
GFAP1 astrocytes was delayed, but GFAP1 cells couldSHP2 and STAT3 were tyrosine phosphorylated upon
be found 7 days later (Figure 2B, middle panel). Thesestimulation of gp130 in the gp130H/H EFs, whereas the
data suggest that STAT3 is required for the formation oftyrosine phosphorylation of SHP2 and STAT3 was abro-
GFAP1 astrocytes, but CNTF and OSM, which activategated in the gp130F759/F759 and the gp130FXXQ/FXXQ EFs, re-
STAT3 through LIF receptor b, could compensate forspectively (Figure 1C). Neither SHP2 nor STAT3 was
the lack of gp130-mediated STAT3 signals. Consistentphosphorylated on tyrosine in the gp130D/D EFs (Figure
with these results, GFAP1 astrocytes were detected in1C). These results established that the mutations of Tyr-
the marginal zone (MZ) of the cervical spinal cord in759 and the tyrosines in the YXXQ motifs selectively
wild-type E18.5 mice but not in the gp130D/D mice (Figureinhibited the gp130-dependent activation of SHP2 and
2C). In contrast, normal numbers of GFAP1 astrocytesSTAT3, respectively.
in the MZ were observed in the gp130FXXQ/FXXQ mice (Fig-Furthermore, the gp130-dependent ERK activation was
ure 2C), suggesting that, in vivo, IL-6 family cytokinesstrongly reduced in the gp130F759/F759 EFs, although TPA-
such as CNTF and LIF are involved in the generation ofstimulated ERK activation was normal (Figure 1D). Tyro-
astrocytes.sine phosphorylation of gp130, JAK1, and STAT3 was
prolonged in gp130F759/F759 EFs (Figure 1E). These data
gp130F759/F759 Mice Display Splenomegaly,suggest that gp130-dependent SHP2 signals positively
Lymphadenopathy, an Enhancedregulate ERK activation but negatively regulate other
Acute-Phase Response, and angp130-dependent signals, in particular, STAT3 activation.
Augmented IgG2a and IgG2b
Response against TD AntigenThe STAT3 Signal Is Required
Although the gp130F759/F759 mice seemed to develop nor-for Embryonic Development
mally, they displayed splenomegaly and lymphadenopa-Homozygous gp130H/H and gp130F759/F759 mice appeared
thy. These problems were first recognizable in most ofnormal at birth (Figure 2A), developed normally, and
the 11-week-old gp130F759/F759 mice, and the size of theirwere fertile. Homozygous gp130D/D mice survived until
spleen and lymph nodes increased with age (Figures 3Athe perinatal period (Table 1). However, fewer than 25%
and 3B). At 5 months of age, enlargement of theof the pups that survived beyond E14.5 were homozy-
lymphoid organs was observed in the spleen and cervi-gous, indicating that some of the gp130D/D embryos died
cal, axillar, inguinal, and mesenteric lymph nodes, butbefore E14.5 (Table 1). All of the gp130D/D homozygotes
not in the thymus, bone marrow, or Peyer's patches.that were born died within 1 day (data not shown). The
Total cell numbers in the spleen, lymph nodes, and peri-gp130FXXQ/FXXQ mice were born according to Mendelian
toneum increased by 1.3- to 2.7-fold in the gp130F759/F759inheritance, but all the homozygote pups died within 1
mice compared with the wild-type littermates (Figure
day (Table 1), like the gp130D/D mice. These results sug-
3B). Immunohistological analysis showed that the struc-
gest that the gp130-mediated STAT3 signal is involved
tures of the lymphoid organs were intact (data not
in the development and/or functions of organs that are shown). In the enlarged lymphoid organs, the numbers
required for survival. of CD31 T cells (both CD41 and CD81 cells), CD45R1
The body size of the newborn gp130D/D and gp130F759/F759 B cells, and CD11b1 myeloid cells all increased by 1.5-
mice was normal, compared with the wild-type lit- to 4-fold. The number of peritoneal B-1a cells (m1CD51),
termates and the gp130H/H mice (Figure 2A). The hearts however, was not altered, and the expression patterns
of the gp130D/D and gp130FXXQ/FXXQ mice looked normal of BCR m and d chains on conventional B cells were the
and appeared to function properly; histological sections same as in the wild-type mice (data not shown). These
showed a normal ventricular wall and septa (data not results suggest that the SHP2 signal negatively regu-
shown). Their liver, lung, kidney, pancreas, and gut also lates the proliferation and/or cell survival of T, B, and
appeared normal, although it is not certain how well myeloid cells, but not of B-1 cells.
they functioned (data not shown). They also responded The concentrations of serum amyloid A and comple-
to touch and moved their legs (data not shown). ment component 3 (C3) were higher in the gp130F759/F759
mice (p , 0.05 and p , 0.005, respectively) than in their
STAT3 in Astrocyte Differentiation wild-type littermates (Figure 4A). When IL-6 was injected
The formation of neurospheres by striatum and cerebral intravenously, the levels of acute-phase proteins in-
cortex of the E14.5 mouse in response to EGF (Reynolds duced were higher in the gp130F759/F759 mice (Figure 4A).
and Weiss, 1992; Reynolds et al., 1992) was normal in Serum immunoglobulin levels of 9-week-old
the gp130F759/F759, gp130FXXQ/FXXQ, and gp130D/D mice (data gp130F759/F759 mice were normal (data not shown). When
not shown), suggesting that gp130 is dispensable for the gp130F759/F759 mice were immunized with thymus-
the formation of neural stem cells in vivo. When neural dependent (TD) antigen (DNP-KLH), they showed en-
hanced antigen-specific immunoglobulin production ofexplants from wild-type mice were cultured in the
Immunity
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Figure 2. Essential Roles of STAT3-Mediated Signals in Perinatal Survival and Neuronal Development
(A) Appearance of newborn homozygous knockin mice. The mice homozygous for the gp130FXXQ/FXXQ and gp130D/D alleles, unlike the gp130H/H
and gp130F759/F759 alleles, do not contain milk in their stomachs.
(B) In vitro differentiation of fetal brain cells into astrocytic cells. Neural explants of cerebral cortices from the E14.5 mice were cultured with
the indicated cytokines for the indicated periods. Values represent average percentages of GFAP1 cells versus total cells. Open bars and
closed bars indicate the values from the wild-type and knockin mice (gp130F759/F759, gp130FXXQ/FXXQ, and gp130D/D), respectively. Error bars indicate
standard deviation.
(C) Lack of GFAP1 cells in the marginal zone of the cervical spinal cords from gp130D/D mice. Horizontal sections of cervical spinal cords from
the E18.5 knockin mice were stained with fluorescence-labeled anti-GFAP antibody.
IgG2a and IgG2b (Figure 4B). On the other hand, their The Role of gp130 in Hematopoiesis
CFU-E (colony-forming unit-erythroid), CFU-GEMMimmune responses to thymus independent (TI) antigens
(TNP-Ficoll and TNP-LPS) were comparable to those of (-granulocyte erythroid macrophage megakaryocyte),
CFU-GM (-granulocyte macrophage), CFU-G (-granulo-their littermates (data not shown), indicating that the
gp130F759/F759 mutation specifically affected the TD re- cyte), and CFU-M (-macrophage) derived from E14.5 fetal
liver cells were normal in the gp130H/H, gp130Y759F/Y759F,sponse. These data suggest that the SHP2 signal nega-
tively regulates the acute-phase response and the IgG2a gp130FXXQ/FXXQ, and gp130D/D mice, when IL-3 and erythro-
poietin (EPO) were used as stimuli (data not shown).and IgG2b production in response to TD antigens.
Table 1. Genotypes of Offspring Derived from Heterozygote Matings
Genotype
Line Age 1/1 1/2 2/2 Total
gp130H/H newborn 62 (36) 79 (45) 33 (19) 174
gp130F759/F759 newborn 90 (24) 211 (56) 74 (20) 375
gp130FXXQ/FXXQ E14.5 20 (23) 48 (56) 18 (21) 76
newborn 20 (15) 47 (35) 32 (24) 74
gp130D/D E14.5 44 (29) 96 (62) 14 (9) 154
newborn 31 (30) 60 (57) 14 (13) 105
The number of each genotype (1/1, wild-type homozygotes; 1/2, heterozygotes; and 2/2, knockin homozygotes) of E14.5 and newborn
mice are indicated. In parenthesis, the frequency (%) of each genotype is indicated. Resorbed embryos were excluded from the data.
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transplantation (data not shown). Total cell numbers in
the bone marrow, thymus, spleen, lymph nodes, and
peritoneum of the transplanted mice were not signifi-
cantly altered, no matter which knockin mouse was used
as a donor. The numbers of WBC, RBC, and platelets
in the peripheral blood of the recipient mice were also
unchanged, and the same was true for the proportion
of CD41 and CD81 T cells, IgD1 B cells, and CD11b1
myeloid cells in the spleen and lymph nodes (data
not shown). In contrast, the population of B-1a cells
(m1CD51) in the peritoneum was reduced by 45% in
the mice that received the gp130FXXQ/FXXQ fetal liver cells.
These results indicate that, with the exception of B-1
cells, the gp130-mediated signals are not strictly re-
quired for the differentiation of most hematopoietic
cells, at least cell autonomously.
Reconstitution Experiments Reveal the Importance
of STAT3-Mediated Signaling in the
Immunoglobulin Response
The serum concentrations of the immunoglobulin iso-
types in mice transplanted with the gp130F759/F759 fetal
liver cells (gp130F759/F759 reconstituted mice) were compa-
rable with those in the mice transplanted with wild-type
fetal liver cells (wild-type reconstituted mice) (Figure
5A). In contrast, serum IgG levels, especially IgG2a and
IgG2b, were lower in mice transplanted with the gp130D/D
fetal liver cells (gp130D/D reconstituted mice) and those
transplanted with the gp130FXXQ/FXXQ fetal liver cells
Figure 3. gp130F759/F759 Mice Show Splenomegaly and Lymphade- (gp130FXXQ/FXXQ reconstituted mice) had lower levels than
nopathy in the wild-type reconstituted mice (Figure 5A). When
(A) Splenomegaly and lymphadenopathy in gp130F759/F759 mice. The the gp130FXXQ/FXXQ reconstituted mice were immunized
spleen and superficial inguinal lymph nodes of an 11-week-old with DNP-KLH, both the primary and secondary induc-
gp130F759/F759 homozygous mouse and its wild-type littermate.
tion of antigen-specific IgG2a and IgG2b were impaired(B) Numbers of cells in the spleen, lymph node, and peritoneal
(Figure 5B).exudate of 11-week-old and 5-month-old mice. Open and closed
circles indicate the numbers of cells in gp130WT/WT (WT, wild-type)
and gp130F759/F759 samples, respectively, and open triangles indicate Reciprocal Roles for the SHP2 and STAT3 Signals
those in gp130WT/F759. Horizontal bars represent the mean values of in Cytokine Production by T Cells and CD40-
each group. The number of cells in one inguinal lymph node is
Mediated Antibody Production by B Cellsshown for the LN data.
When spleen cells from gp130F759/F759 mice were stimu-
lated with an anti-CD3 antibody in vitro, they produced
more IFNg than did those from their wild-type littermatesIL-7 induced CFU-pre-B was also normal in these mice.
In contrast, the gp130FXXQ/FXXQ and gp130D/D, but not the (1.6-fold) (Figure 6A). In contrast, spleen cells from the
gp130FXXQ/FXXQ reconstituted mice showed decreasedgp130F759/F759 mutant, showed significant reduction in
CFU-M when M-CSF (macrophage colony stimulating IFNg production compared with those from the wild-
type reconstituted mice (0.6-fold) (Figure 6A). Next, wefactor) was used as a stimulus (94.6 6 23.8, 44.0 6 22.1,
and 136.2 6 2.6, respectively). FACS analyses of CD4, stimulated CD41 T cells isolated from the spleens of
gp130F759/F759 mice with anti-CD3 and CD28 antibodies.CD8, CD25, and CD44 fetal thymocytes at E14.5 and
E18.5 revealed that the development of T cell progeni- The T cells from the gp130F759/F759 mice produced more
IFNg (1.5-fold) and less IL-4 (0.6-fold) than those of con-tors was not affected in the gp130F759/F759 and gp130D/D
mice (data not shown). The hematocrit of fetal blood trol mice (Figure 6B). These results imply that the STAT3
and SHP2 signals relayed through gp130 reciprocallywas normal at E14.5 and E18.5 (data not shown). These
data suggest that the gp130-mediated signals are dis- regulate the balance of Th1 versus Th2 cytokine produc-
tion in T cells.pensable for the development of hematopoietic progeni-
tor cells. We next examined the immunoglobulin production of
B cells in response to anti-CD40 antibody and IL-6.To explore the roles of the gp130-mediated signals
in the differentiation of hematopoietic cells and the im- When small resting B cells were stimulated with anti-
CD40 antibody alone, the gp130F759/F759 B cells producedmune response, fetal liver cells from the E14.5 knockin
mice (gp130H/H, gp130F759/F759, gp130FXXQ/FXXQ, and gp130D/D) all the IgGs at higher levels than did the wild-type B
cells (Figure 6C, upper panel). Costimulation with bothwere transplanted to lethally irradiated 8- to 10-week-
old B6C3F1 mice. For all the mutants, the transplanted anti-CD40 antibody and IL-6 further enhanced the IgG
production by the gp130F759/F759 B cells (Figure 6C, upperhematopoietic cells repopulated the peripheral blood
and lymphoid organs and replaced more than 90% panel). In contrast, stimulation with anti-CD40 antibody
and IL-6 had only marginal effects on IgG productionof the recipient population by 8±9 weeks after the
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Figure 4. Enhanced Acute-Phase Response
and Augmented IgG2a and IgG2b Response
against TD Antigen in gp130F759/F759 Mice
(A) gp130F759/F759 and gp130WT/F759 mice were
injected intravenously with 10 mg of rIL-6
through the retroorbital plexus. Serum con-
centration of amyloid A (left panel) and C3
(right panel) were determined. Concentra-
tions of C3 were indicated as values relative
to the average concentration in gp130WT/F759
serum at time 0. Symbols represent individual
values for gp130F759/F759 (closed circles, n 5 6)
and gp130WT/F759 mice (open circles, n 5 6).
Lines represent pairs of littermates.
(B) Augmented TD responses in gp130F759/F759
mutant mice. Sera were taken at 14 days after
the primary immunization with DNP-KLH.
Symbols represent values for individual
gp130WT/WT (open circles, n 5 3), gp130WT/F759
(open triangles, n 5 8), and gp130F759/F759
(closed circles, n 5 8) mice, and horizontal
bars represent the mean values of each
group. Statistical comparisons are by Stu-
dent's t test.
by the gp130FXXQ/FXXQ B cells (Figure 6C, lower panel). The results. In addition to the gp130-deficient mice, defects
in hematopoiesis are also reported for IL-6- and LIF-proliferation of the B cells in response to these stimuli
deficient mice (Escary et al., 1993; Kopf et al., 1995).was not significantly changed in the gp130F759/F759 and
Here, colony assays showed that gp130-mediated sig-the gp130FXXQ/FXXQ B cells compared with the wild-type
nals are dispensable for the development of hematopoi-B cells (data not shown). These data suggest that the
etic systems. The difference between the numbers ofSTAT3 signal is required for the IL-6-induced enhance-
CFUs we obtained and those reported for gp130-, IL-6-,ment of antibody production in B cells stimulated by
and LIF-deficient mice may be due to differences inCD40 and that the SHP2 signal is involved in its negative
the supplemented factors used in the analyses. Theregulation.
synergistic effects of IL-6 and colony stimulating fac-
tors (CSF) on colony formation has been describedDiscussion
previously (Metcalf and Nicola, 1995), and the lack of
gp130-mediated signals may affect certain CSF-depen-Generation of Knockin Mice
dent colony formation, such as CFU-M. The transplanta-We generated knockin mouse lines in which different
tion experiments further support the dispensable rolesignals relayed through gp130 were individually or to-
of gp130-mediated signals in hematopoiesis.tally disrupted. The gp130D/D mice are expected to lack
Biochemical analysis of the gp130F759/F759 andall the signals relayed through gp130, since they only
gp130FXXQ/FXXQ EFs established that Tyr-759 and theexpressed a soluble gp130 that lacked the transmem-
YXXQ motifs are required for the tyrosine phosphoryla-brane and cytoplasmic domains. These mice were simi-
tion of SHP2 and STAT3, respectively, consistent withlar to gp130-deficient mice that were previously de-
studies using chimeric receptors and cell lines. Our anal-
scribed (Yoshida et al., 1996). Some of the gp130D/D
yses also support the previous notion that Tyr-759 is
homozygotes died before E14.5, but most of them died required for gp130-dependent ERK activation and that
within 1 day of birth. Similarly, the previously described it is involved in the negative regulation of tyrosine phos-
gp130-deficient mice display embryonic lethality at phorylation and the activation of gp130, JAK1, and
E12.5 and E16.5, but the embryonic stage at which death STAT3. These data verify our strategy for individual inac-
occurs varies, depending on their genetic background tivation of the gp130-mediated signals in vivo. Our strat-
(Kawasaki et al., 1997). However, the gp130D/D mice dis- egy was further confirmed by in vitro GFAP1 astrocyte
played different phenotypes from the gp130-deficient differentiation assays using neural explants from the
mice and the conditional gp130-targeted mice, which knockin mice. Differentiation of GFAP1 astrocytes in
have heart defects and problems with hematopoietic response to IL-6 and the soluble IL-6 receptor was se-
progenitor cell development (Yoshida et al., 1996; Betz verely perturbed in the gp130FXXQ/FXXQ mice. Expression
et al., 1998). In contrast, the gp130D/D mice displayed of GFAP was previously shown to be induced by the
almost normal development of these systems (data not gp130-mediated STAT3 signals in vitro (Bonni et al.,
shown). With respect to heart defects, ventricular mus- 1997), and gp130 is required for the development of
cle±specific disruption of the gp130 gene demonstrated GFAP1 astrocytes in vivo (Nakashima et al., 1999).
that the gp130-mediated signals are not required, at Consistently, differentiation of GFAP1 astrocytes in re-
least cell autonomously, for embryonic development of sponse to IL-6 and the soluble IL-6 receptor was se-
verely perturbed in the gp130FXXQ/FXXQ mice.the heart (Hirota et al., 1999). Our data support their
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Figure 5. Decreased Antibody Production in Reconstituted Mice Transplanted with Fetal Liver Cells from gp130FXXQ/FXXQ
(A) Decreased basal serum levels of immunoglobulins in the reconstituted gp130D/D and gp130FXXQ/FXXQ mice. Serum levels of the immunoglobulin
isotypes in the reconstituted mice transplanted with the fetal liver cells of gp130F759/F759 (upper panel), gp130FXXQ/FXXQ (middle panel), and gp130D/D
(lower panel) mice were determined. Symbols represent the values of individual gp130F759/F759, gp130FXXQ/FXXQ, and gp130D/D reconstituted mice
(closed circles, n 5 5, 8, and 5, respectively) and wild-type reconstituted mice (open circles, n 5 6, 10, and 5, respectively). Horizontal bars
represent the mean values of each group. Significant differences by Student's t tests are indicated by asterisks (*p , 0.05, **p , 0.01, and
***p , 0.005).
(B) Decreased TD antigen-specific antibody production by the reconstituted gp130FXXQ/FXXQ mice. Serum concentrations of DNP-specific
antibodies 14 days after the primary immunization (upper panel) and a week after boosting (lower panel) are indicated. Symbols represent
the values for individual gp130FXXQ/FXXQ reconstituted mice (closed circles, n 5 8) and wild-type reconstituted mice (open circles, n 5 8).
Horizontal bars represent the mean values of each group. Significant differences by Student's t tests are indicted by asterisks (*p , 0.05 and
***p , 0.005).
Although the SHP2- and STAT3-mediated signals gp130F759/F759 mice as well as the gp130F759/F759 recon-
stituted mice, TD antigen-specific IgG2a and IgG2bwere selectively affected in the gp130F759/F759 and
gp130FXXQ/FXXQ mice, it remains possible that the muta- production was upregulated (data not shown for the
gp130F759/F759 reconstituted mice). Production of immuno-tions might affect other signaling cascades via gp130,
such as Tec, Btk, Hck, and Fes (Ernst et al., 1994; Hirano, globulins by the purified gp130F759/F759 B cells was also up-
regulated. However, in the gp130FXXQ/FXXQ reconstituted1998; Oh et al., 1998). Although STAT3 is a major STAT
activated through gp130, STAT1 and STAT5 are also mice, these responses were severely impaired. Similarly,
IFNg production by T cells increased in the gp130F759/F759activated (Hemmann et al., 1996; Fujitani et al., 1997).
The mutations of Tyr-759 and/or the YXXQ motifs might and decreased in the gp130FXXQ/FXXQ T cells. Furthermore,
the gp130F759/F759 mice showed splenomegaly and lympho-modify activities of these molecules. Analysis on these
molecules in individual tissues and tissue-specific inac- adenopathy and an enhanced acute-phase reaction.
Taken together, these results indicate that an appro-tivation of SHP2 and STAT3 will further clarify specific
roles of gp130-mediated SHP2 and STAT3 signals in vivo. priate balance of the positive and negative signals gen-
erated through gp130 is critical for the immune re-
sponses. In this study, the negative signal, which wasThe Balance of Positive and Negative Signals
through gp130 Determines the Homeostasis of lost in the gp130F759/F759 mice, was most likely dependent
on the SHP2 signal's negative regulation of the gp130-the Lymphoid Organs and Immunoglobulin
and Cytokine Response mediated STAT3 signal. In fact, the biochemical data
showed prolonged tyrosine phosphorylation of STAT3The gp130F759/F759 mice displayed opposite phenotypes
to the gp130FXXQ/FXXQ mice at various points. In the in the gp130F759/F759 EFs. Consistent with this observation,
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Previous reports (Fukada et al., 1996) and biochemical
analysis using the gp130F759/F759 EFs established that the
SHP2 signal mediates a positive regulatory signal re-
layed through gp130 to ERK MAP kinases. Although this
signal was lost in the gp130F759/F759 mice, most of their
observed phenotypes could be explained by antago-
nism of the STAT3 signals. This result suggests that the
loss of the SHP2 signal to the ERK MAP kinase may be
compensated for by other signal transduction cascades
in vivo in the gp130F759/F759 mice. It is possible that ERK
activated through the SHP2 signal may be involved in
the negative regulation of the STAT3 signals. Supporting
this idea, ERK MAP kinase is reported to be involved in
the downregulation of the phosphorylation of STAT3
(Jain et al., 1998; Sengupta et al., 1998). In any case,
the negative regulation of STAT3 may be an inevitable
role of the SHP2 signal in vivo. Further analysis of the
gp130F759/F759 mice may clarify the positive roles of the
SHP2 signal in vivo.
The Role of gp130 in the Immunoglobulin Response
Essential roles for the IL-6/gp130 system in the humoral
immune responses have been evidenced by the impair-
ment of the antibody responses to TD antigens in IL-6-
deficient mice and dominant-negative gp130-express-
ing transgenic mice (Kopf et al., 1995; Kumanogoh et
al., 1997). The gp130F759/F759 mice exhibited enhanced
IgG2a and IgG2b production in response to TD antigens.
In contrast, the gp130FXXQ/FXXQ reconstituted mice had
impaired IgG2a and IgG2b production in response to TD
antigens. These results suggest that the STAT3 signal is
required for TD antigen-responsive IgG2a and IgG2b
production and that it is negatively controlled by the
SHP2 signal. Because it was unclear how the gp130-
mediated signals affected the TD antigen-responsive
antibody production, we analyzed the functions of T and
Figure 6. Reciprocal Th1/Th2 Type Cytokine Production by T Cells B cells in the knockin mice and the reconstituted mice.
and Immunoglobulin Production by B Cells from gp130F759/F759 and
IFNg production was increased in the gp130F759/F759gp130FXXQ/FXXQ Mice
spleen cells and decreased in the gp130FXXQ/FXXQ spleen(A) In vitro IFNg production by spleen cells from the gp130F759/F759
cells. Furthermore, purified T cells from the gp130F759/F759mice and gp130FXXQ/FXXQ reconstituted mice. IFNg produced by whole
mice produced increased levels of IFNg and decreasedspleen cells stimulated with anti-CD3 from gp130F759/F759 (closed bar)
was compared to that from the wild-type littermates (open bar, levels of IL-4 compared with those from their wild-type
n 5 6, left panel). IFNg from gp130FXXQ/FXXQ mice (closed bar) was littermates. IFNg and IL-4 are representative cytokines
compared to that from the wild-type reconstituted mice (open bar, for Th1 and Th2 responses, respectively (Mosmann and
n 5 3, right panel). Values represent average percentages against
Sad, 1996). IL-6 is implicated in the development of Th1the wild-type control. Error bars indicate standard deviation.
cells (Romani et al., 1996; Ladel et al., 1997; Suzuki et(B) Reciprocal effects of the gp130F759/F759 mutation on the production
al., 1997). Our data provide evidence that the gp130-of IFNg and IL4 by helper T cells. In vitro IFNg and IL-4 production
by splenic helper T cells of the gp130F759/F759 mice were analyzed. mediated STAT3 signal biases development of naive T
Data are represented as the cytokine concentration values obtained cells toward Th1 and that the SHP2 signal is negatively
from the gp130F759/F759 culture (closed bars) relative to the values involved in this process. Since IFNg is known to induce
obtained from the wild-type culture (open bars). The mean values
the class switch to IgG2a (Snapper et al., 1988), theof five independent experiments are shown.
increased production of IgG2a in the gp130F759/F759 mice(C) Effects of IL-6 on IgG production were augmented in gp130F759/F759
may be partly explained by this bias.B cells. Purified resting B cells were incubated with anti-CD40 anti-
body with or without IL-6 for 5 days. Representative data from B cell functions were also affected by the gp130 muta-
independent experiments using gp130F759/F759 mice (five experiments, tions. The production of IgGs in response to IL-6 and
upper panel) and the reconstituted gp130FXXQ/FXXQ mice (three experi- CD40 stimulation was increased and decreased in the
ments, lower panel) are shown.
resting gp130F759/F759 and gp130FXXQ/FXXQ B cells, respec-
tively, compared with the wild-type B cells. These effects
were observed for all the IgG isotypes and thus cannotan enhanced acute-phase response, for which the STAT3
signal is essential, was observed in the gp130F759/F759 be explained simply by a preferential class switch. The
data suggest that the gp130-mediated STAT3 signal ismice. The negative regulatory role of SHP2 was also
suggested for the IL-2 receptor system in vivo (Fujii et cell autonomously required for the proper IgG produc-
tion in B cells. In vivo, TD antigen-dependent IgG2aal., 1998).
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anti-Jak1 (H-106, Santa-Cruz), anti-SHP2 (C-18, Santa-Cruz), anti-and IgG2b production was preferentially affected in the
gp130 (RMb1, MBL, Japan), anti-ERK2 (C-14, Santa-Cruz), and anti-gp130F759/F759 and gp130FXXQ/FXXQ reconstituted mice. It is
active MAPK (Promega) were used in this study.likely that a combination of abnormal functions in T and
B cells, and possibly antigen presenting cells (APC), Primary Cultures of Cortical Cells, Immunocytochemistry,
contributes to the phenotypes observed in these mice. and Immunostaining of Tissue Sections
Furthermore, we observed a reduced number of perito- Cerebral cortices were removed from E14.5 embryos and dissoci-
ated by brief mechanical trituration. The cells were cultured on poly-neal B-1 cells in the gp130FXXQ/FXXQ and gp130D/D reconsti-
ethylenimine-coated glass coverslips in the presence of CNTF (100tuted mice, suggesting that the STAT3 signal is required
ng/ml), OSM (100 ng/ml), or IL-6 (20 ng/ml) plus sIL-6R (25 ng/for the development of B-1 cells. Our data, and a previ-
ml), and subjected to indirect immunocytochemistry as described
ous report showing STAT3 is constitutively activated in previously (Kaneko et al., 1999). Immunohistochemical analysis of
B-1 cells, suggest that gp130-mediated signaling may the embryos was performed as described previously (Sakakibara
be involved in the constitutive activation of STAT3 in et al., 1996; Kaneko et al., 1999). Anti-GFAP antibody (Sigma) was
used in this study.B-1 cells (Karras et al., 1997).
In summary, gp130-mediated STAT3 and SHP2 sig-
Immunizationnals are involved in the homeostasis of the lymphoid
Eight- to twelve-week-old mice were injected intraperitoneally withorgans, multiple steps of the immune response, and
100 mg of DNP-KLH (LSL, Japan) precipitated with 4 mg of alum
the development and functions of various organs. The (LSL) on day 0 and were boosted with 20 mg of DNP-KLH in saline
present results show that the balance of positive and on day 21. Blood was taken through the retroorbital plexus every 7
negative signals elicited through a given cytokine recep- days. To examine the TI responses, 50 mg of TNP-LPS (prepared in
this laboratory) or 20 mg of TNP-FICOLL (Biosearch Technologies)tor determines the final output of the biological activities
were intraperitoneally injected.of a given cytokine in vivo (Hirano et al., 1997; Hirano,
1999). Experiments using our knockin mice should con-
ELISAtinue to shed light on the mechanisms by which gp130
The ELISA assays for antibody detection was described previously
regulates biological functions through distinct signal (Itoh et al., 1998). To determine the concentration of complement 3
transduction pathways in vivo. (C3), a rat monoclonal antibody against mouse C3 (clone RMC11H9,
Cedarlane) and peroxidase-conjugated goat anti-mouse C3 anti-
body (Cappel) were used. The concentrations of serum amyloidExperimental Procedures
A, IFNg, and IL4 were determined using a commercial ELISA kit
(Biosource International).Construction of Targeting Vectors and Generation
of Targeted Mice
ReconstitutionA l FixII 129/Sv mouse strain genomic library (Stratagene) was
Fetal liver cells (3 3 106) of knockin mice (H-2b) or control micescreened by hybridization with the entire coding fragment of the
were injected intravenously into B6C3F1 mice (H-2b/k) that had beenhuman gp130 cDNA probe (Hibi et al., 1990). To construct targeting
irradiated with 1300 rad of X-rays (Rigaku kikai) on the previousvectors (for gp130H/H, gp130F759/F759, and gp130FXXQ/FXXQ), the 5.2 kb
day. Eight-to-nine weeks after injection, the reconstituted mice wereBglII±EcoRI fragment of mouse gp130 genomic DNA, the EcoRI±
subjected to a variety of analysis. Donor-derived hematopoietic cellsXhoI fragment (the XhoI site was generated by subcloning) of human
in the lymphoid organs were detected as H-2Kk-negative cells bygp130 cDNA or its mutant cDNAs, the XhoI±EcoRI fragment of
multicolor flow cytometric analysis. Donor-originated cells repopu-pMCneoA, the 1.2 kb BstEII±BglII fragment of mouse gp130 genomic
lated more than 90% of hematopoietic cells in the reconstitutedDNA, and the XhoI fragment of the thymidine kinase gene were
mice.subcloned into the EcoRI and XhoI sites of pBluescript SK1. The
EcoRI site of the extracellular domain of gp130, which is conserved
between the mouse and human gp130 genes, was used to connect Preparation and Culture of T and B Cells
human gp130 cDNA with the mouse gp130 genomic DNA. The cDNA Spleen cells were obtained from 12- to 20-week-old mice and were
for the gp130 mutant in which Tyr-759 was replaced by a phenylala- treated with 0.165 M Tris-NH4Cl to lyse erythrocytes. Whole spleen
nine was previously reported and used to construct the targeting cells were cultured at 106/ml in the presence of plate-immobilized
vector for the gp130F759/F759 mice (Yamanaka et al., 1996). The gp130 anti-CD3 antibody (145-2C11, 5 mg/ml) for 48 hr. Splenic CD41
mutant in which Tyr-767, -814, -905, and -915 were replaced by helper T cells were enriched with anti-CD4 antibody±conjugated
phenylalanines was constructed by ligating the EcoRI±AccI fragment magnetic beads (Miltenyi) and a Mini MACS column (Miltenyi).
of G-F3 to the AccI±XhoI fragment of G-Fall (Fukada et al., 1996) Helper T cells (purity .95%) were cultured at 106/ml in the presence
and used to construct the targeting vector for the gp130FXXQ/FXXQ of plate-immobilized anti-CD3 antibody and soluble anti-CD28 anti-
mice. To construct the targeting vector for the gp130D/D mice, the body (Pharmingen, 1 mg/ml) for 3 days. The cells were then har-
opal stop codon was introduced at position 610 (of the human vested, washed, and plated at 106/ml in the presence of plate-immo-
gp130) by a PCR-based method. Detailed sequences are available bilized anti-CD3 antibody for 24 hr.
on request. Targeted mice were generated as described previously Small resting B cells were isolated from spleen cells by a combina-
(Itoh et al., 1998), and the genotypes of the mice were identified by tion of discontinuous Percoll centrifugation (Snapper et al., 1988)
PCR and Southern blotting analysis. and anti-CD45R-conjugated magnetic beads. The resting B cells
(.95% IgM-positive cells) were cultured at 5 3 105/ml with 1 mg/
ml anti-CD40 monoclonal antibody (clone 3/23, PharMingen) in thePreparation and Stimulation of Embryonic Fibroblasts
Embryonic fibroblasts were prepared from E14.5±15.5 embryos and presence or absence of 100 ng/ml IL-6.
cultured in Dulbecco's modified Eagle's medium (DMEM) containing
10% FCS. EFs were starved for FCS for 12 hr and stimulated with Flow Cytometric Analysis
IL-6 (Ajinomoto, Tokyo, Japan) and soluble IL-6 receptor a (kindly Details of the method for flow cytometric analysis were described
provided by Dr. K. Yasukawa, Tosoh). previously (Ishihara et al., 1996; Itoh et al., 1998). Purified rat anti-
mouse gp130 monoclonal antibody (RX187) was provided by Dr.
Mikiyoshi Saito and labeled with FITC by standard procedure. Anti-Immunoprecipitation and Immunoblotting
Immunoprecipitation and immunoblotting were performed as de- mouse monoclonal antibodies, PE-anti-CD4 (clone RM4±4), and
CyChrome-anti-CD45R (clone RA3±6B2) were purchased from Phar-scribed previously (Fukada et al., 1998). The immune complex was
visualized by a chemiluminescence system (Renaissance, DuPont Mingen. Quantum-red-anti-CD8a (clone 53-6.7), and biotinylated
anti-H-2Kk (clone CT Kk) were purchased from Sigma and Caltag,New England Nuclear). Anti-STAT3 antisera (Kojima et al., 1996),
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respectively. Biotinylated antibodies were detected with FITC-, phy- Hirano, T., Nakajima, K., and Hibi, M. (1997). Signaling mechanisms
through gp130: a model of the cytokine system. Cytokine Growthcoerythrin (PE)-, or peridinin chlorophyll-alpha protein (PerCP)-
Factor Rev. 8, 241±252.labeled streptavidin.
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